New hope for pancreatic cancer: drug combo trial launches
Disease control
Recruiting now
This study tests a combination of two drugs (adebrelimab and chidamide) plus standard chemotherapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this mix can slow tumor growth and help patients live longer. About 45 adults who…
Phase: PHASE2 • Sponsor: Liu Xiufeng • Aim: Disease control
Last updated May 11, 2026 20:40 UTC